Articles From: U.S. Waterfront Home Values Twice as High as Overall Home Values to NPS Pharma Stock Trading Halted Today; FDA Advisory Committee to Review Natpara® Biologics License Application


2014/9/12
New waterfront analysis calculates median value of waterfront, single-family homes in 250 U.S. cities - Nationwide, the median single-family home is valued at $171,600, while the typical lake or oceanfront house is worth $370,900. - Among large cities, biggest premiums for waterfront single-family homes found in Tampa, Honolulu and Long Beach.
Sign-up for U.S. Waterfront Home Values Twice as High as Overall Home Values investment picks
Results Suggest that Oncotype DX® Colon Cancer Test May Reduce Medical Costs Associated with Stage II Disease While Increasing Patient Well-being REDWOOD CITY, Calif.
Sign-up for Genomic Health Announces Publication of Colon Cancer Cost-Effectiveness Study in PharmacoEconomics investment picks
New Olleh GiGA UHD(4K) Set-top Box Delivers Vivid Ultra HD Content to South Korean Subscribers AMSTERDAM , Sept.
Sign-up for Korea Telecom Launches Broadcom-enabled Ultra HD IPTV Service investment picks
Darden Restaurants (DRI) said it will review the operational plan proposed by Starboard Value, one of the restaurant operator's largest shareholders, but it believes many of the plan's strategies are already being implemented.
Sign-up for Darden says aspects of Starboard's transformation plan already being implemented investment picks
By Sue Chang and Victor Reklaitis, MarketWatch NEW YORK (MarketWatch) -- These are the companies whose shares are expected to see active trade in Friday's session.
Sign-up for UPDATE: Ulta, Darden jump after earnings reports investment picks
2014/9/12
Ryder System, Inc .
Sign-up for Food Logistics Names Ryder a Top 3PL & Cold Storage Provider investment picks
2014/9/12
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- Futures for U.S. stocks indicated a flat open for Wall Street on Friday, ahead of the release of data that may show an increase in monthly retail sales and improved consumer sentiment in the world's largest economy.
Sign-up for UPDATE: U.S. stocks: Futures flat; consumers in the spotlight investment picks
ORLANDO, Fla.
Sign-up for Darden Issues Statement Regarding Starboard's Operational Plan investment picks
-- Leading Provider in Managed Mobility Solutions to Present on September 18, 2014 --
Sign-up for WidePoint Corporation to Present at The 5th Annual Craig-Hallum Alpha Select Conference In New York investment picks
Rimrock Midstream, LLC and NGL Energy Partners LP (NYSE:NGL) are pleased to announce a binding open season starting next Monday, September 15 th at 8:00am Central Standard Time for their joint venture Grand Mesa Pipeline, LLC (“Grand Mesa”) crude oil pipeline.
Sign-up for Rimrock Midstream, LLC and NGL Energy Partners LP Announce Grand Mesa Pipeline Open Season Starting Monday, September 15, 2014 investment picks
Darden Restaurants' (DRI) second-largest shareholder, Starboard Value, detailed its transformation plan for the restaurant chain operator that could boost the share price to $67 to $86, or 39% to 78% above Thursday's closing price of $48.29. The plan includes company-wide operational improvement, a turnaround plan for Darden's Olive Garden business, separating the company's restaurant brands and real estate assets and a new franchising program.
Sign-up for Darden Restaurants shareholder detail plan to boost share price investment picks
NGL Energy Partners LP (NYSE:NGL) and Rimrock Midstream, LLC are pleased to announce a binding open season starting next Monday, September 15 th at 8:00 a.m. Central Standard Time for their joint venture Grand Mesa Pipeline, LLC (“Grand Mesa”) crude oil pipeline.
Sign-up for NGL Energy Partners LP and Rimrock Midstream, LLC Announce Grand Mesa Pipeline Open Season Starting Monday, September 15, 2014 investment picks
Today Biogen Idec (NASDAQ: BIIB) and AbbVie (NYSE: ABBV) announced the full results from the Phase 3 DECIDE clinical trial, which show ZINBRYTA™ (daclizumab high-yield process), dosed subcutaneously once a month, demonstrated a statistically significant improvement in reducing disease activity in people with relapsing-remitting multiple sclerosis (RRMS) compared to AVONEX ® (interferon beta-1a). These results are being presented at the Sixth Triennial Joint Meeting of the Americas Committee for Treatment and Research in Multiple Sclerosis and the European Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS-ECTRIMS) in Boston.
Sign-up for Detailed Results from Biogen Idec and AbbVie’s Pivotal Phase 3 Decide Study Further Define the Efficacy and Safety Profile of ZINBRYTA™ (Daclizumab High-Yield Process) investment picks
2014/9/12
NEW YORK , Sept.
Sign-up for Ada Investments Announces Strategic Investment By XL Group investment picks
INDIANAPOLIS , Sept.
Sign-up for Allison Transmission CEO selected as recipient of Louis V. Gerstner Jr. Excellence Award investment picks
AGC of Idaho and Textura Form Partnership Canada NewsWire CHICAGO , Sept.
Sign-up for AGC of Idaho and Textura Form Partnership investment picks
CHICAGO , Sept.
Sign-up for AGC of Idaho and Textura Form Partnership investment picks
2014/9/12
Provides Guidance on the First Fiscal Quarter 2015 and Fiscal Year 2015 Revenues and Net Incomes XI'AN, China, Sept.
Sign-up for China Green Agriculture Reports Fiscal Year 2014 Financial Results investment picks
EMCOR Group, Inc. (NYSE:EME), a Fortune 500 ® leader in mechanical and electrical construction, industrial and energy infrastructure, and building services for a diverse range of businesses, announced that its subsidiary Harry Pepper & Associates, Inc .
Sign-up for EMCOR Group, Inc. Subsidiary Awarded Contract for Rehabilitation and Structural Replacement Work on Herbert Hoover Dike, Florida investment picks
2014/9/12
Pre-Orders Now Available Online att.com/iPhone Customers Can Get iPhone For No Money Down and $100 Bill Credit with New Line of Service on AT&T Next DALLAS , Sept.
Sign-up for AT&T to Offer iPhone 6 & iPhone 6 Plus on the Nation's Most Reliable 4G LTE Network That Covers More Than 300 Million People investment picks
RALEIGH, N.C., Sept.
Sign-up for Baxano Surgical to Train 35 Surgeons on Advanced MIS Techniques investment picks
2014/9/12
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- Europe's benchmark stock index headed for its first weekly loss in five weeks on Friday, reflecting concerns that Scotland could vote to leave the United Kingdom next week.
Sign-up for EUROPE MARKETS: Stoxx Europe 600 Heads For 0.8% Weekly Loss investment picks
2014/9/12
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- Europe's benchmark stock index headed for its first weekly loss in five weeks on Friday, reflecting concerns that Scotland could vote to leave the United Kingdom next week.
Sign-up for UPDATE: Stoxx Europe 600 heads for 0.8% weekly loss investment picks
2014/9/12
By Chester Yung Hong Kong property developer Sun Hung Kai Properties Ltd.
Sign-up for Sun Hung Kai Properties Fiscal Year Underlying Net Profit Up 15% investment picks
2014/9/12
By Laurence Witherington And Henry Williams Diaper wars rage around the globe as big-name brands battle for the loyalty of new moms.
Sign-up for Diapers: Which Countries Prefer to Have Them at Their Disposal? investment picks
Darden Restaurants (DRI) reported a fiscal first-quarter adjusted profit, which excluded non-recurring items, of 32 cents a share, exceeding the FactSet consensus analyst estimate of 31 cents a share.
Sign-up for Darden Restaurants beats profit, sales forecasts investment picks
AXIS Capital Holdings Limited ("AXIS Capital") (NYSE:AXS) today announced that the Company’s Board of Directors has declared a quarterly dividend of $0.27 per common share.
Sign-up for AXIS Capital Declares Quarterly Dividends on Common and Preferred Shares investment picks
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today announced that NASDAQ has halted trading of the company’s common stock.
Sign-up for NPS Pharma Stock Trading Halted Today; FDA Advisory Committee to Review Natpara® Biologics License Application investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: U.S. Waterfront Home Values Twice as High as Overall Home Values to NPS Pharma Stock Trading Halted Today; FDA Advisory Committee to Review Natpara® Biologics License Application
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices